搜尋結果
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 2 日前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...
The 10 Best Performing Stocks So Far In 2024
Forbes· 2 日前The stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June ...
China's institutional opening-up in financial sector offers global market opportunities
Bastillepost· 2 日前China's promotion of high-level institutional opening up in the financial sector has ...
The No. 1 regret people have when they die, from an ex-hospice worker—and how to get ahead of it
CNBC· 2 日前People on their deathbed share a single most-common regret: "I wish I'd had the ...
Pitch Deck Teardown: Feel Therapeutics' $3.5M seed deck
TechCrunch· 2 日前Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable devices, mobile ...
This three-time Olympian juggled medical school with training for Paris 2024: 'I would not ...
CNBC· 2 日前Kat Holmes is used to being asked how she pulled off the near-impossible feat of qualifying for ...
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 2 日前Shares of the biopharma company surged 30% after the U.S. Food and Drug Administration approved ...
Sarepta's Stock Soars on Best-Case FDA Decision for its Muscular Dystrophy Treatment
The Wall Street Journal· 2 日前For biotech companies, regulatory approval is usually one of many steps needed to convince Wall ...
Exclusive | Kaiser Permanente Unit to Acquire North Carolina Hospital System
The Wall Street Journal· 2 日前The acquisition of Cone Health is part of an ambitious effort to build a national network that ...
Secretary for Health deeply concerned about management of public healthcare system
Bastillepost· 2 日前The Health Bureau (HHB) is deeply concerned about the multiple recent incidents in relation to ...